Dr. Parikh Discusses Liquid Biopsies in Gastrointestinal Cancers

Aparna Parikh, MD
Published: Friday, Jun 30, 2017



Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal (GI) cancers.

In an effort to better understand acquired resistance to targeted therapies in GI cancers, investigators collected plasma via liquid biopsy at disease progression for next-generation sequencing of circulating tumor DNA.

Tissue biopsies may not capture the entirety of the tumor in terms of heterogeneity, says Parikh.

<<< View more from the 2017 World Congress on GI Cancer


Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal (GI) cancers.

In an effort to better understand acquired resistance to targeted therapies in GI cancers, investigators collected plasma via liquid biopsy at disease progression for next-generation sequencing of circulating tumor DNA.

Tissue biopsies may not capture the entirety of the tumor in terms of heterogeneity, says Parikh.

<<< View more from the 2017 World Congress on GI Cancer

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
x